Cancer and mTOR inhibitors in kidney transplantation recipients

Cancer and mTOR inhibitors in kidney transplantation recipients

Background Previous studies show that mTOR inhibitors decrease the risk of cancer development after kidney transplantation. However, the effect of cumulative doses of mTOR inhibitors on cancer after kidney transplantation is not well known. Methods In the current study, patients were registered into...

Full description

Bibliographic Details
Main Authors:	Chih-Chin Kao, Jia-Sin Liu, Yu-Kang Chang, Ming-Huang Lin, Yen-Chung Lin, Hsi-Hsien Chen, Wei-Chiao Chang, Chih-Cheng Hsu, Mai-Szu Wu
Format:	Article
Language:	English
Published:	PeerJ Inc. 2018-11-01
Series:	PeerJ
Subjects:	Chronic kidney disease Cancer Kidney transplantation Mortality mTOR inhibitors
Online Access:	https://peerj.com/articles/5864.pdf

Similar Items

Role of mTOR Inhibitors in Kidney Disease
by: Moto Kajiwara, et al.
Published: (2016-06-01)

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients
by: Antony Brayan Campos-Salazar, et al.
Published: (2018-11-01)

mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
by: Simona Granata, et al.
Published: (2021-08-01)

Long-Term Redistribution of Peripheral Lymphocyte Subpopulations after Switching from Calcineurin to mTOR Inhibitors in Kidney Transplant Recipients
by: Laura Llinàs-Mallol, et al.
Published: (2020-04-01)

Is Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients? A Systemic Review of Medium-term Outcomes
by: J Kumar, et al.
Published: (2017-04-01)

AMPK/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury
by: Ying Wang, et al.
Published: (2020-12-01)

Cyclophosphamide Inhibits PI3K/AKT/mTOR Signaling Pathway in Mice Kidneys
by: Gulsah Albayrak, et al.
Published: (2018-12-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01)

mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01)

Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities
by: Julio Pascual, et al.
Published: (2017-05-01)

Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the Effect of Maintenance Immunotherapy
by: María Iglesias-Escudero, et al.
Published: (2020-04-01)

SIRT3 Protects Against Acute Kidney Injury via AMPK/mTOR-Regulated Autophagy
by: Wenyu Zhao, et al.
Published: (2018-11-01)

Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment
by: Dennis Heinzen, et al.
Published: (2019-09-01)

mTOR Inhibitors in Advanced Biliary Tract Cancers
by: Chao-En Wu, et al.
Published: (2019-01-01)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
by: James T. Murray, et al.
Published: (2018-05-01)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
by: Tian Tian, et al.
Published: (2019-02-01)

Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
by: Alexandre el Hage, et al.
Published: (2021-03-01)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
by: Kirby Sean, et al.
Published: (2012-03-01)

Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant
by: Pil Soo Sung, et al.
Published: (2021-07-01)

Critical analysis of graft loss and death in kidney transplant recipients treated with mTOR inhibitors
by: Luis Gustavo Modelli de Andrade, et al.

mTOR Pathways in Cancer and Autophagy
by: Mathieu Paquette, et al.
Published: (2018-01-01)

Apoptosis repressor with caspase recruitment domain deficiency accelerates ischemia/reperfusion (I/R)-induced acute kidney injury by suppressing inflammation and apoptosis: The role of AKT/mTOR signaling
by: Ke Yingjie, et al.
Published: (2019-04-01)

Targeting mTOR as a Therapeutic Approach in Medulloblastoma
by: Juncal Aldaregia, et al.
Published: (2018-06-01)

Cyclic AMP-dependent signal transduction leading to mitogenesis in thyroid. Implication of the mammalian target of rapamycin (mTOR).
by: Blancquaert, Sara
Published: (2010)

Developing Viral Strategies to Study mTOR and its Regulators as Mediators of Epileptogenesis
by: Gulati, Ruhi
Published: (2019)

mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly
by: Camila A. B. Garcia, et al.
Published: (2020-03-01)

Conversion to mTOR-inhibitors with calcineurin inhibitor elimination or minimization reduces urinary polyomavirus BK load in kidney transplant recipients
by: Chieh-Li Yen, et al.
Published: (2016-07-01)

Mesenchymal Stem Cell Protects Injured Renal Tubular Epithelial Cells by Regulating mTOR-Mediated Th17/Treg Axis
by: Yongsheng Luo, et al.
Published: (2021-05-01)

The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis
by: Nannan Gao, et al.
Published: (2018-08-01)

mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership
by: Angel Cayo, et al.
Published: (2021-07-01)

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Regulates Neurite Outgrowth Through the Activation of Akt/mTOR and Erk/mTOR Signaling Pathways
by: Wen Wen, et al.
Published: (2020-09-01)

The mTOR Signalling Pathway in Human Cancer
by: Paula Soares, et al.
Published: (2012-02-01)

Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
by: Nazanin Momeni Roudsari, et al.
Published: (2021-08-01)

Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma
by: Luca Felkai, et al.
Published: (2020-07-01)

Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s Disease
by: Zhou Zhu, et al.
Published: (2019-02-01)

mTOR inhibition: a promise for a young heart.
by: Stêfany Bruno De Assis Cau, et al.
Published: (2012-02-01)

Dose-dependent Effects of mTOR Inhibition on Weight and Mitochondrial Disease in Mice
by: Simon C Johnson, et al.
Published: (2015-07-01)

Metformin induces degradation of mTOR protein in breast cancer cells
by: Mohamed Alalem, et al.
Published: (2016-11-01)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
by: Kerstin Tiedemann, et al.
Published: (2017-05-01)

mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms
by: Samantha Exner, et al.
Published: (2021-02-01)